Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outpatient Management of Patients Conditioned with Fludarabine and Treosulfan prior to Allogeneic Hematopoietic Cell Transplantation.
Schovsbo JS, Kjeldsen L, Nørskov KH, Sengeløv H, Kornblit BT, Schjødt I, Petersen SL, Nygaard M, Andersen NS, Mortensen BK, Friis LS. Schovsbo JS, et al. Among authors: friis ls. Transplant Cell Ther. 2025 Jan;31(1):28.e1-28.e10. doi: 10.1016/j.jtct.2024.11.001. Epub 2024 Nov 9. Transplant Cell Ther. 2025. PMID: 39522721 Free article.
Pretransplantation Plasma ST2 Level as a Prognostic Biomarker of 1-Year Nonrelapse Mortality in Allogeneic Hematopoietic Cell Transplantation.
Gjærde LK, Ostrowski SR, Schierbeck F, Andersen NS, Friis LS, Kornblit B, Petersen SL, Schjødt I, Sengeløv H. Gjærde LK, et al. Among authors: friis ls. Transplant Cell Ther. 2023 Feb;29(2):97.e1-97.e6. doi: 10.1016/j.jtct.2022.11.009. Epub 2022 Nov 11. Transplant Cell Ther. 2023. PMID: 36375798 Free article.
Triple-Drug Graft-versus-Host Disease Prophylaxis after HLA-Matched Unrelated Donor Nonmyeloablative Allogenic Hematopoietic Stem Cell Transplantation.
Wegener A, Andersen NS, Friis LS, Petersen SL, Schjødt I, Kornblit B, Sengeløv H, Gjærde LK. Wegener A, et al. Among authors: friis ls. Transplant Cell Ther. 2023 Sep;29(9):575.e1-575.e6. doi: 10.1016/j.jtct.2023.05.022. Epub 2023 Jun 9. Transplant Cell Ther. 2023. PMID: 37301257 Free article. Clinical Trial.
Donor Lymphocyte Infusion Is a Feasible Way to Improve Survival in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Who Relapse after Allogeneic Stem Cell Transplantation.
Minculescu L, Reekie J, Petersen SL, Kornblit BT, Schjoedt I, Andersen NS, Andersen LP, Fischer-Nielsen A, Haastrup EK, Friis LS, Sengelov H. Minculescu L, et al. Among authors: friis ls. Acta Haematol. 2024;147(3):325-332. doi: 10.1159/000534315. Epub 2023 Oct 12. Acta Haematol. 2024. PMID: 37827141
Evaluation and management of hepatic dysfunction, portal hypertension and portal/splanchnic vein thrombosis in patients with myelofibrosis undergoing allogeneic haematopoietic cell transplantation: A practice based survey on behalf of the Chronic Malignancies Working Party of the EBMT.
Battipaglia G, Polverelli N, Tuffnell J, Chiusolo P, Robin M, Gambella M, Broers A, Sala E, Passweg J, Furst S, Friis LS, Dulery R, de Witte M, Srour M, Finazzi MC, Wehr C, Nagler A, Richardson D, Bethge W, Clark A, Drozd-Sokolowska J, Raj K, Czerw T, Hernández-Boluda JC, McLornan DP. Battipaglia G, et al. Among authors: friis ls. Curr Res Transl Med. 2024 Oct 25;73(1):103476. doi: 10.1016/j.retram.2024.103476. Online ahead of print. Curr Res Transl Med. 2024. PMID: 39461096 Free article.
Trends in survival and cure after allogeneic haematopoietic cell transplantation for acute myeloid leukaemia from 2000 to 2020: A Danish population-based cohort study.
Gjaerde LK, Jakobsen LH, Juhl-Christensen C, Olesen G, Petruskevicius I, Severinsen MT, Marcher CW, Theilgaard-Mönch K, Andersen NS, Friis LS, Kornblit B, Petersen SL, Schjødt I, Sengeløv H. Gjaerde LK, et al. Among authors: friis ls. Br J Haematol. 2023 Feb;200(4):e40-e43. doi: 10.1111/bjh.18511. Epub 2022 Oct 20. Br J Haematol. 2023. PMID: 36263998 No abstract available.
Improved survival after allogeneic transplantation for acute lymphoblastic leukemia in adults: a Danish population-based study.
Gjærde LK, Rank CU, Andersen MK, Jakobsen LH, Sengeløv H, Olesen G, Kornblit B, Marquart H, Friis LS, Petersen SL, Andersen NS, Nielsen OJ, Toft N, Schjødt I. Gjærde LK, et al. Among authors: friis ls. Leuk Lymphoma. 2022 Feb;63(2):416-425. doi: 10.1080/10428194.2021.1992620. Epub 2021 Oct 21. Leuk Lymphoma. 2022. PMID: 34672245
Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelomonocytic Leukemia: Clinical and Molecular Genetic Prognostic Factors in a Nordic Population.
Wedge E, Hansen JW, Dybedal I, Creignou M, Ejerblad E, Lorenz F, Werlenius O, Ungerstedt J, Holm MS, Nilsson L, Kittang AO, Antunovic P, Rohon P, Andersen MK, Papaemmanuil E, Bernard E, Jädersten M, Hellström-Lindberg E, Grønbæk K, Ljungman P, Friis LS. Wedge E, et al. Among authors: friis ls. Transplant Cell Ther. 2021 Dec;27(12):991.e1-991.e9. doi: 10.1016/j.jtct.2021.08.028. Epub 2021 Sep 6. Transplant Cell Ther. 2021. PMID: 34500124 Free article.
43 results